Primary CNS Lymphoma

February 11, 2019

Rituxan Plus Chemo Fails to Benefit Newly Diagnosed Primary CNS Lymphoma Patients in Clinical Trial

News

Adding Rituxan (rituximab) to standard first-line chemotherapy did not improve disease outcomes for people with primary central nervous system (CNS) lymphoma in a Phase 3 clinical trial, results show. The ... Read more

October 16, 2015October 16, 2015

Organ Transplant Drug May Increase Risk of Rare Form of Lymphoma

News

Recently, a group of clinical researchers from Johns Hopkins Hospital (JHH) released study results revealing that the immunosuppressive drug mycophenolate mofetil (MMF) may be linked to an increased risk of central ... Read more

September 22, 2015September 22, 2015

Combining MRI with Specific Biomarkers Strengths CNS Lymphoma Diagnosis

News

In a recent study entitled “The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma” authors report that ... Read more

June 26, 2015August 23, 2016

Rituximab and Thiotepa Improves Outcomes in Primary CNS Lymphoma Patients

News

During the recent International Conference on Malignant Lymphoma in Lugano, Switzerland, researchers from the International Extra-nodal Lymphoma Study Group (IELSG) led by Andrés Ferreri, MD, Ospedale San Raffaele, Milano, Italy, presented ... Read more